{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:01:31Z","timestamp":1792555291668,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mcpdigitalhealth.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Digital Health"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mcpdig.2026.100361","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:12:25Z","timestamp":1776384745000},"page":"100361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Data-Driven Stratification Reveals 3 Distinct Clinicopathologic Phenotypes in Renal Thrombotic Microangiopathy"],"prefix":"10.1016","volume":"4","author":[{"given":"Simon","family":"Moubarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-9740","authenticated-orcid":false,"given":"Jing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Priya","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaleh","family":"Zand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"El Ters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9809","authenticated-orcid":false,"given":"Ladan","family":"Zand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mcpdig.2026.100361_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.mcpdig.2026.100361_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcpdig.2026.100361_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mcpdig.2026.100361_bib4","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1053\/j.ajkd.2016.10.006","article-title":"AJKD atlas of renal pathology: thrombotic microangiopathy","volume":"68","author":"Lusco","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MNH.0b013e3283378f25","article-title":"Thrombotic microangiopathy: new insights","volume":"19","author":"Benz","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"21","key":"10.1016\/j.mcpdig.2026.100361_bib6","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mcpdig.2026.100361_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"19","key":"10.1016\/j.mcpdig.2026.100361_bib8","first-page":"327","article-title":"The differential diagnosis and treatment of thrombotic microangiopathies","volume":"115","author":"Bommer","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"10.1016\/j.mcpdig.2026.100361_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.mcna.2016.09.010","article-title":"Syndromes of thrombotic microangiopathy","volume":"101","author":"Shatzel","year":"2017","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2020030239","article-title":"Subtyping CKD patients by consensus clustering: the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"32","author":"Zheng","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcpdig.2026.100361_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data","volume":"52","author":"Monti","year":"2003","journal-title":"Mach Learn"},{"key":"10.1016\/j.mcpdig.2026.100361_bib12","article-title":"UMAP: uniform manifold approximation and projection for dimension reduction","author":"Mclnnes","year":"2020","journal-title":"Preprint"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.semdp.2020.01.002","article-title":"A new paradigm for renal thrombotic microangiopathy","volume":"37","author":"Gallan","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.mcpdig.2026.100361_bib14","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ckj\/sfaa195","article-title":"Thrombotic microangiopathies assessment: mind the complement","volume":"14","author":"Blasco","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.mcpdig.2026.100361_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2021.05.040","article-title":"Systemic autoimmune disorders associated with thrombotic microangiopathy: a cross-sectional analysis from the French National TMA registry: systemic autoimmune disease-associated TMA","volume":"93","author":"Martis","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.mcpdig.2026.100361_bib16","first-page":"e119","article-title":"Gemcitabine-associated thrombotic microangiopathy: response to complement inhibition and reinitiation of gemcitabine","volume":"16","author":"Turner","year":"2017","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.mcpdig.2026.100361_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.ajkd.2010.06.006","article-title":"The role of endothelial cell injury in thrombotic microangiopathy","volume":"56","author":"Goldberg","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.mcpdig.2026.100361_bib18","doi-asserted-by":"crossref","first-page":"c312","DOI":"10.1159\/000319885","article-title":"Nephrotoxicities associated with the use of tyrosine kinase inhibitors: a single-center experience and review of the literature","volume":"117","author":"Jhaveri","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"10.1016\/j.mcpdig.2026.100361_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.mcpdig.2026.100361_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"Buttner-Herold","year":"2021","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcpdig.2026.100361_bib22","article-title":"The loss of glycocalyx integrity impairs complement factor H binding and contributes to cyclosporine-induced endothelial cell injury","volume":"10","author":"Teoh","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.12669\/pjms.303.4558","article-title":"Vascular endothelial growth factor expression in peripheral blood of patients with pregnancy induced hypertension syndrome and its clinical significance","volume":"30","author":"Ren","year":"2014","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.mcpdig.2026.100361_bib24","article-title":"Endothelial dysfunction in hypertension: current concepts and clinical implications","volume":"8","author":"Gallo","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.mcpdig.2026.100361_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf017","article-title":"Kidney outcomes of malignant hypertension-associated thrombotic microangiopathy in patients with and without IgA nephropathy: a propensity score-matched analysis","volume":"18","author":"Li","year":"2025","journal-title":"Clin Kidney J"},{"issue":"16","key":"10.1016\/j.mcpdig.2026.100361_bib26","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2169\/internalmedicine.55.6332","article-title":"Malignant hypertension with thrombotic microangiopathy","volume":"55","author":"Mitaka","year":"2016","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.mcpdig.2026.100361_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.mcpdig.2026.100361_bib28","article-title":"Scleroderma and Renal Crisis","author":"Basyal","year":"2025","journal-title":"StatPearls"},{"issue":"4","key":"10.1016\/j.mcpdig.2026.100361_bib29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000507886","article-title":"Renal involvement in systemic sclerosis: an update","volume":"45","author":"Chrabaszcz","year":"2020","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"10.1016\/j.mcpdig.2026.100361_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/MOH.0000000000000169","article-title":"ADAMTS13 and von Willebrand factor interactions","volume":"22","author":"Zander","year":"2015","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.mcpdig.2026.100361_bib31","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1182\/blood-2023-187248","article-title":"Genetic landscape of thrombotic microangiopathies with focus on plasminogen mutation variants","volume":"142","author":"Agarwal","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mcpdig.2026.100361_bib32","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ndt\/gfac248","article-title":"Thrombotic microangiopathy in patients with malignant hypertension","volume":"38","author":"Cavero","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.mcpdig.2026.100361_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2019.05.014","article-title":"Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome","volume":"96","author":"Cavero","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mcpdig.2026.100361_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ackd.2021.11.006","article-title":"Thrombotic microangiopathy syndromes-common ground and distinct frontiers","volume":"29","author":"Hanna","year":"2022","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["Mayo Clinic Proceedings: Digital Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949761226000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949761226000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:12:06Z","timestamp":1781611926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949761226000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2949761226000271"],"URL":"https:\/\/doi.org\/10.1016\/j.mcpdig.2026.100361","relation":{},"ISSN":["2949-7612"],"issn-type":[{"value":"2949-7612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data-Driven Stratification Reveals 3 Distinct Clinicopathologic Phenotypes in Renal Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Digital Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcpdig.2026.100361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}],"article-number":"100361"}}